ELI LILLY & CO (1LLY.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock
1LLY.MI Key Statistics, Chart & Performance
The current stock price of 1LLY.MI is 923.5 EUR. In the past month the price increased by 0.64%. In the past year, price increased by 20.91%.
1LLY.MI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to 1LLY.MI. When comparing the yearly performance of all stocks, 1LLY.MI is one of the better performing stocks in the market, outperforming 78.32% of all stocks.
1LLY.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI. 1LLY.MI scores excellent on profitability, but there are some minor concerns on its financial health.
1LLY.MI Financial Highlights
Over the last trailing twelve months 1LLY.MI reported a non-GAAP Earnings per Share(EPS) of 18.79. The EPS increased by 116.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 30.99% | ||
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| Debt/Equity | 1.72 |
1LLY.MI Forecast & Estimates
37 analysts have analysed 1LLY.MI and the average price target is 960.46 EUR. This implies a price increase of 4% is expected in the next year compared to the current price of 923.5.
For the next year, analysts expect an EPS growth of 84.97% and a revenue growth 41.38% for 1LLY.MI
1LLY.MI Ownership
About 1LLY.MI
Company Profile
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The firm is also engaged in radiopharmaceutical discovery, development, and manufacturing efforts, and clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). The company is evaluating its novel gene therapy candidate, ixoberogene soroparvovec.
Company Info
ELI LILLY & CO
Lilly Corporate Ctr, Drop Code 1094
Indianapolis INDIANA US
Employees: 47000
Phone: 13172762000
ELI LILLY & CO / 1LLY.MI FAQ
What does 1LLY do?
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The firm is also engaged in radiopharmaceutical discovery, development, and manufacturing efforts, and clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). The company is evaluating its novel gene therapy candidate, ixoberogene soroparvovec.
What is the stock price of ELI LILLY & CO today?
The current stock price of 1LLY.MI is 923.5 EUR. The price increased by 3.73% in the last trading session.
What is the dividend status of ELI LILLY & CO?
ELI LILLY & CO (1LLY.MI) has a dividend yield of 0.67%. The yearly dividend amount is currently 4.25.
What is the ChartMill technical and fundamental rating of 1LLY stock?
1LLY.MI has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in ELI LILLY & CO be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1LLY.MI.
Can you provide the ownership details for 1LLY stock?
You can find the ownership structure of ELI LILLY & CO (1LLY.MI) on the Ownership tab.